Mair Therapeutics
PrivateLast Round
Pre Seed
Feb 13, 2025
Company Overview
Mair Therapeutics is a biotechnology company that develops therapies for neurodegenerative diseases, with a primary focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mair Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Mair Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 13, 2025 |
Mair Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Expert Systems Inc. | Pre Seed |
| Torrey Pines Investment LLC | Pre Seed |
| Oost NL | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2025
Secured Pre Seed funding from Torrey Pines Investment, Expert Systems, and Oost NL.
Mair Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mair Therapeutics's valuation, stock price, and market status.
